Nom du produit:1-(3,5-dimethoxyphenyl)-6-ethoxy-3-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)-1,4-dihydropyridazin-4-one

IUPAC Name:1-(3,5-dimethoxyphenyl)-6-ethoxy-3-(1,2,3,4-tetrahydroisoquinoline-2-carbonyl)-1,4-dihydropyridazin-4-one

CAS:1251619-21-2
Formule moléculaire:C24H25N3O5
Pureté:95%+
Numéro de catalogue:CM790730
Poids moléculaire:435.48

Unité d'emballage Stock disponible Prix($) Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:1251619-21-2
Formule moléculaire:C24H25N3O5
Point de fusion:-
Code SMILES:CCOC1=CC(=O)C(=NN1C1=CC(OC)=CC(OC)=C1)C(=O)N1CCC2=C(C1)C=CC=C2
Densité:
Numéro de catalogue:CM790730
Poids moléculaire:435.48
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Pyridazines
Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.
Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.